학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 15건 | 목록
1~20
Academic Journal
Erdem M; Experimental and Clinical Research Center, Charité-Universitätsmedizin Berlin and Max-Delbrück-Center for Molecular Medicine, Translational Oncology of Solid Tumors Research Group, 13125 Berlin, Germany.; Lee KH; Experimental and Clinical Research Center, Charité-Universitätsmedizin Berlin and Max-Delbrück-Center for Molecular Medicine, Translational Oncology of Solid Tumors Research Group, 13125 Berlin, Germany.; Hardt M; Experimental and Clinical Research Center, Charité-Universitätsmedizin Berlin and Max-Delbrück-Center for Molecular Medicine, Translational Oncology of Solid Tumors Research Group, 13125 Berlin, Germany.; Regan JL; Bayer AG, Research and Development, Pharmaceuticals, 13342 Berlin, Germany.; JLR Life Sciences Ltd., A96 A8D5 Dublin, Ireland.; Kobelt D; Experimental and Clinical Research Center, Charité-Universitätsmedizin Berlin and Max-Delbrück-Center for Molecular Medicine, Translational Oncology of Solid Tumors Research Group, 13125 Berlin, Germany.; German Cancer Consortium, 69120 Heidelberg, Germany.; Walther W; Experimental and Clinical Research Center, Charité-Universitätsmedizin Berlin and Max-Delbrück-Center for Molecular Medicine, Translational Oncology of Solid Tumors Research Group, 13125 Berlin, Germany.; Mokrizkij M; Experimental and Clinical Research Center, Charité-Universitätsmedizin Berlin and Max-Delbrück-Center for Molecular Medicine, Translational Oncology of Solid Tumors Research Group, 13125 Berlin, Germany.; Regenbrecht C; CELLphenomics GmbH, 13125 Berlin, Germany.; Stein U; Experimental and Clinical Research Center, Charité-Universitätsmedizin Berlin and Max-Delbrück-Center for Molecular Medicine, Translational Oncology of Solid Tumors Research Group, 13125 Berlin, Germany.; German Cancer Consortium, 69120 Heidelberg, Germany.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Academic Journal
Regan JL; Charité Comprehensive Cancer Centre, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.; Smalley MJ; European Cancer Stem Cell Research Institute, School of Biosciences, Cardiff University, Hadyn Ellis Building, Wales, CF24 4HQ UK.
Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: eCollection Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE
Academic Journal
Regan JL; Bayer AG, Research and Development, Pharmaceuticals, 13342 Berlin, Germany.; Charité Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, 10117 Berlin, Germany.; Schumacher D; Laboratory of Molecular Tumor Pathology, Charité Universitätsmedizin Berlin, 10117 Berlin, Germany.; German Cancer Consortium (DKTK), DKFZ, 69120 Heidelberg, Germany.; Staudte S; Bayer AG, Research and Development, Pharmaceuticals, 13342 Berlin, Germany.; German Cancer Consortium (DKTK), DKFZ, 69120 Heidelberg, Germany.; Department of Radiation Oncology and Radiotherapy, Charité - Universitätsmedizin Berlin, 10117 Berlin, Germany.; Steffen A; Bayer AG, Research and Development, Pharmaceuticals, 13342 Berlin, Germany.; Lesche R; Bayer AG, Research and Development, Pharmaceuticals, 13342 Berlin, Germany.; Nuvisan ICB GmbH, 13353 Berlin, Germany.; Toedling J; Bayer AG, Research and Development, Pharmaceuticals, 13342 Berlin, Germany.; Nuvisan ICB GmbH, 13353 Berlin, Germany.; Jourdan T; Bayer AG, Research and Development, Pharmaceuticals, 13342 Berlin, Germany.; Haybaeck J; Institute of Pathology, Neuropathology and Molecular Pathology, Medical University of Innsbruck, 6020 Innsbruck, Austria.; Diagnostic and Research Center for Molecular Biomedicine, Institute of Pathology, Medical University of Graz, 8036 Graz, Austria.; Golob-Schwarzl N; Institute of Pathology, Neuropathology and Molecular Pathology, Medical University of Innsbruck, 6020 Innsbruck, Austria.; Department of Dermatology and Venereology, Medical University of Graz, 8036 Graz, Austria.; Mumberg D; Bayer AG, Research and Development, Pharmaceuticals, 13342 Berlin, Germany.; Henderson D; Bayer AG, Research and Development, Pharmaceuticals, 13342 Berlin, Germany.; Bayer AG, Business Development and Licensing and Open Innovation, Pharmaceuticals, 13342 Berlin, Germany.; Győrffy B; Department of Bioinformatics, Semmelweis University, 1094 Budapest, Hungary.; TTK Cancer Biomarker Research Group, Institute of Enzymology, 1117 Budapest, Hungary.; Regenbrecht CRA; Laboratory of Molecular Tumor Pathology, Charité Universitätsmedizin Berlin, 10117 Berlin, Germany.; CELLphenomics GmbH, 13125 Berlin, Germany.; Institute of Pathology, University Medical Center Göttingen, 37075 Göttingen, Germany.; Keilholz U; Charité Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, 10117 Berlin, Germany.; Schäfer R; Charité Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, 10117 Berlin, Germany.; Laboratory of Molecular Tumor Pathology, Charité Universitätsmedizin Berlin, 10117 Berlin, Germany.; German Cancer Consortium (DKTK), DKFZ, 69120 Heidelberg, Germany.; Lange M; Bayer AG, Research and Development, Pharmaceuticals, 13342 Berlin, Germany.; Nuvisan ICB GmbH, 13353 Berlin, Germany.
Publisher: Cell Press Country of Publication: United States NLM ID: 101724038 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-0042 (Electronic) Linking ISSN: 25890042 NLM ISO Abbreviation: iScience Subsets: PubMed not MEDLINE
Academic Journal
Regan JL; Charité Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, 10117 Berlin, Germany.
Publisher: Cell Press Country of Publication: United States NLM ID: 101769501 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-1667 (Electronic) Linking ISSN: 26661667 NLM ISO Abbreviation: STAR Protoc Subsets: MEDLINE
Academic Journal
Klutzny S; Bayer AG, Drug Discovery, 13353, Berlin, Germany.; Institute for Biotechnology, Bioanalytics, Technical University Berlin, 13355, Berlin, Germany.; Anurin A; Bayer AG, Drug Discovery, 13353, Berlin, Germany.; Nicke B; Bayer AG, Drug Discovery, 13353, Berlin, Germany.; Regan JL; Bayer AG, Drug Discovery, 13353, Berlin, Germany.; Lange M; Bayer AG, Drug Discovery, 13353, Berlin, Germany.; Schulze L; Bayer AG, Drug Discovery, 13353, Berlin, Germany.; Parczyk K; Bayer AG, Drug Discovery, 13353, Berlin, Germany.; Steigemann P; Bayer AG, Drug Discovery, 13353, Berlin, Germany. patrick.steigemann@bayer.com.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-4889 (Electronic) NLM ISO Abbreviation: Cell Death Dis Subsets: MEDLINE
Academic Journal
Regan JL; Charité - Universitätsmedizin Berlin, Berlin, Germany. Electronic address: joseph.regan@charite.de.
Publisher: Academic Press Country of Publication: United States NLM ID: 0373334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 0091-679X (Print) Linking ISSN: 0091679X NLM ISO Abbreviation: Methods Cell Biol Subsets: MEDLINE
Academic Journal
Regan JL; Bayer AG, Research & Development, Pharmaceuticals, 13342 Berlin, Germany.; Charité Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, 10117 Berlin, Germany.; Schumacher D; Laboratory of Molecular Tumor Pathology, Charité Universitätsmedizin Berlin, 10117 Berlin, Germany.; German Cancer Consortium (DKTK), DKFZ, 69120 Heidelberg, Germany.; Staudte S; Bayer AG, Research & Development, Pharmaceuticals, 13342 Berlin, Germany.; German Cancer Consortium (DKTK), DKFZ, 69120 Heidelberg, Germany.; Department of Radiation Oncology and Radiotherapy, Charité Universitätsmedizin Berlin, 10117 Berlin, Germany.; Steffen A; Bayer AG, Research & Development, Pharmaceuticals, 13342 Berlin, Germany.; Lesche R; Bayer AG, Research & Development, Pharmaceuticals, 13342 Berlin, Germany.; Nuvisan ICB GmbH, 13353 Berlin, Germany.; Toedling J; Bayer AG, Research & Development, Pharmaceuticals, 13342 Berlin, Germany.; Nuvisan ICB GmbH, 13353 Berlin, Germany.; Jourdan T; Bayer AG, Research & Development, Pharmaceuticals, 13342 Berlin, Germany.; Haybaeck J; Institute of Pathology, Neuropathology and Molecular Pathology, Medical University of Innsbruck, A-6020 Innsbruck, Austria.; Diagnostic & Research Center for Molecular Biomedicine, Institute of Pathology, Medical University of Graz, 8036 Graz, Austria.; Mumberg D; Bayer AG, Research & Development, Pharmaceuticals, 13342 Berlin, Germany.; Henderson D; Bayer AG, Research & Development, Pharmaceuticals, 13342 Berlin, Germany.; Győrffy B; Department of Bioinformatics, Semmelweis University, 1094 Budapest, Hungary.; TTK Cancer Biomarker Research Group, Institute of Enzymology, 1117 Budapest, Hungary.; Regenbrecht CRA; Laboratory of Molecular Tumor Pathology, Charité Universitätsmedizin Berlin, 10117 Berlin, Germany.; CELLphenomics GmbH, 13125 Berlin, Germany.; Institute of Pathology, University Medical Center Göttingen, 37075 Göttingen, Germany.; Keilholz U; Charité Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, 10117 Berlin, Germany.; Schäfer R; Charité Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, 10117 Berlin, Germany.; Laboratory of Molecular Tumor Pathology, Charité Universitätsmedizin Berlin, 10117 Berlin, Germany.; German Cancer Consortium (DKTK), DKFZ, 69120 Heidelberg, Germany.; Lange M; Bayer AG, Research & Development, Pharmaceuticals, 13342 Berlin, Germany.; Nuvisan ICB GmbH, 13353 Berlin, Germany.
Publisher: Cell Press Country of Publication: United States NLM ID: 101724038 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-0042 (Electronic) Linking ISSN: 25890042 NLM ISO Abbreviation: iScience Subsets: PubMed not MEDLINE
Academic Journal
Schumacher D; Charité Comprehensive Cancer Center, Charité Universitätsmedizin Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center Heidelberg, Heidelberg, Germany.; Regan JL; Charité Comprehensive Cancer Center, Charité Universitätsmedizin Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center Heidelberg, Heidelberg, Germany.; Przybilla D; Charité Comprehensive Cancer Center, Charité Universitätsmedizin Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center Heidelberg, Heidelberg, Germany.; Schäfer R; Charité Comprehensive Cancer Center, Charité Universitätsmedizin Berlin, Berlin, Germany. reinhold.schaefer@charite.de.; German Cancer Consortium (DKTK), German Cancer Research Center Heidelberg, Heidelberg, Germany. reinhold.schaefer@charite.de.
Publisher: Humana Press Country of Publication: United States NLM ID: 9214969 Publication Model: Print Cited Medium: Internet ISSN: 1940-6029 (Electronic) Linking ISSN: 10643745 NLM ISO Abbreviation: Methods Mol Biol Subsets: MEDLINE
Academic Journal
Smalley MJ; European Cancer Stem Cell Research Institute, Cardiff School of Biosciences, Cardiff University, Museum Avenue, Cardiff, UK. SmalleyMJ@Cardiff.ac.uk; Kendrick H; Sheridan JM; Regan JL; Prater MD; Lindeman GJ; Watson CJ; Visvader JE; Stingl J
Publisher: Kluwer Academic/Plenum Publishers Country of Publication: United States NLM ID: 9601804 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7039 (Electronic) Linking ISSN: 10833021 NLM ISO Abbreviation: J Mammary Gland Biol Neoplasia Subsets: MEDLINE
Academic Journal
Britt, Kara L; Kendrick, Howard; Regan, Joseph L; Molyneux, Gemma; Magnay, Fiona-Ann; Ashworth, Alan; Smalley, Matthew J
Breast Cancer Res
Breast Cancer Research, vol 11, iss 2
Breast Cancer Research, vol 11, iss 2
Academic Journal
Kendrick H; Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK. howard.kendrick@icr.ac.uk; Regan JL; Magnay FA; Grigoriadis A; Mitsopoulos C; Zvelebil M; Smalley MJ
Publisher: BioMed Central Country of Publication: England NLM ID: 100965258 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2164 (Electronic) Linking ISSN: 14712164 NLM ISO Abbreviation: BMC Genomics Subsets: MEDLINE
Academic Journal
Smalley, Matthew J; Iravani, Marjan; Leao, Maria; Grigoriadis, Anita; Kendrick, Howard; Dexter, Tim; Fenwick, Kerry; Regan, Joseph L; Britt, Kara; McDonald, Sarah; Lord, Christopher J; MacKay, Alan; Ashworth, Alan
Breast Cancer Res
Breast Cancer Research, vol 9, iss 6
Breast Cancer Research, vol 9, iss 6
Academic Journal
Regan JL; Charité Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.; Bayer AG, Drug Discovery, Pharmaceuticals, 10117 Berlin, Germany.
Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101642411 Publication Model: eCollection Cited Medium: Print ISSN: 2372-3556 (Print) Linking ISSN: 23723556 NLM ISO Abbreviation: Mol Cell Oncol Subsets: PubMed not MEDLINE
Academic Journal
Regan JL; Bayer AG, Drug Discovery, Pharmaceuticals, 13342 Berlin, Germany; Charité Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany. Electronic address: joseph.regan@charite.de.; Schumacher D; Laboratory of Molecular Tumor Pathology, Charité Universitätsmedizin Berlin, 10117 Berlin, Germany; German Cancer Consortium (DKTK), DKFZ, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.; Staudte S; Bayer AG, Drug Discovery, Pharmaceuticals, 13342 Berlin, Germany; Charité Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.; Steffen A; Bayer AG, Drug Discovery, Pharmaceuticals, 13342 Berlin, Germany.; Haybaeck J; Department of Pathology, Medical Faculty, Otto von Guericke University Magdeburg, Leipziger Straße 44, Haus 28, 39120 Magdeburg, Germany; Institute of Pathology, Medical University Graz, Auenbruggerplatz 25, 8036 Graz, Austria.; Keilholz U; Charité Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.; Schweiger C; Institute of Pathology, Medical University Graz, Auenbruggerplatz 25, 8036 Graz, Austria.; Golob-Schwarzl N; Institute of Pathology, Medical University Graz, Auenbruggerplatz 25, 8036 Graz, Austria.; Mumberg D; Bayer AG, Drug Discovery, Pharmaceuticals, 13342 Berlin, Germany.; Henderson D; Bayer AG, Drug Discovery, Pharmaceuticals, 13342 Berlin, Germany.; Lehrach H; Max Planck Institute for Molecular Genetics, Ihnestrasse 73, 14195 Berlin, Germany.; Regenbrecht CRA; Charité Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany; cpo - cellular phenomics & oncology Berlin-Buch GmbH, Robert-Rössle-Straße 10, 13125 Berlin, Germany.; Schäfer R; Charité Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany; Laboratory of Molecular Tumor Pathology, Charité Universitätsmedizin Berlin, 10117 Berlin, Germany; German Cancer Consortium (DKTK), DKFZ, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.; Lange M; Bayer AG, Drug Discovery, Pharmaceuticals, 13342 Berlin, Germany. Electronic address: martin.lange@bayer.com.
Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE
Academic Journal
Regan JL; Division of Breast Cancer Research, Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK.; Sourisseau T; Soady K; Kendrick H; McCarthy A; Tang C; Brennan K; Linardopoulos S; White DE; Smalley MJ
Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Regan, Joseph L
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어